Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
Clinical trial NCT03324373 · COMPLETED
Trial details
- NCT number
- NCT03324373
- Sponsor
- Yousef Zakharia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2023-09-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.